Nephrolyx
1 known investors
Nephrolyx develops the IVDx system, combining an IVD kit with GFRx software that integrates into laboratory LIMS to measure glomerular filtration rate (mGFR) via iohexol plasma clearance for kidney function diagnostics in clinical routine. It serves physicians, clinical laboratories, and pharma/biotech companies conducting kidney research, and also offers the DNPx digital platform for research use.